Prescription drug abuse | Addiction Professional Magazine Skip to content Skip to navigation

Prescription drug abuse

Marrying science and design to improve access to naloxone

July 24, 2017  |  Gary A. Enos, Editor
blog
University professors used their collective talents to create a device allowing easy access to the opioid overdose reversal drug naloxone.

Three keys to lowering mortality rates in opioid disorder patients

July 21, 2017  |  Alison Knopf, Contributing Writer
article
New research has found that providing psychosocial counseling and avoiding prescribed opioids or benzodiazepines are among the variables that can reduce mortality rates in opioid use disorders. Medication treatment did not affect death rates.

Report offers state-by-state breakdown of non-medical prescription drug use

July 14, 2017  |  Gary A. Enos, Editor
news
A new report from the Substance Abuse and Mental Health Services Administration (SAMHSA) shows that the prevalence of non-medical use of prescription opioids in 2012-2014 was highest in Oklahoma and lowest in Minnesota.

Partnership in R.I. will accelerate buprenorphine training

July 13, 2017  |  Gary A. Enos, Editor
article
An expanded addictions curriculum in Brown University's medical school will allow some young doctors to qualify immediately to prescribe buprenorphine for opioid dependence.

Outstanding Clinical Care Award: Stanley Street Treatment and Resources Opioid Triage Center

July 12, 2017  |  Gary A. Enos, Editor
article
Individuals affected by the opioid crisis are benefiting from an expansion of SSTAR's open-access model of service.

Center addresses triangle of pain, addictive and psychological disorders

July 10, 2017  |  Gary A. Enos, Editor
article
A California facility that calls itself the first "triple diagnosis" program is seeking to make inroads with a variety of privately and publicly funded treatment populations.

Drug maker agrees to stop selling Opana ER because of misuse

July 7, 2017  |  Julie Miller, Editor in Chief
news
Endo Pharmaceuticals on Thursday agreed to remove its long-acting Opana ER pain drug from the market, following an FDA request that it stop selling the product because of incidents of misuse.

Place medication in the rightful context

June 27, 2017  |  Gary A. Enos, Editor
blog
A number of experts in the addiction field would like to see use of the term "medication-assisted treatment" eradicated, saying that it perpetuates stigma.

Few young people with opioid dependence have received medication

June 21, 2017  |  Gary A. Enos, Editor
news
A Boston Medical Center study has found that just over one-quarter of adolescents and young adults diagnosed with an opioid use disorder from 2001-2014 received a prescription for buprenorphine or naltrexone.

NIH, private partners team up on opioid crisis initiative

June 19, 2017  |  Tom Valentino, Senior Editor
article
The National Institutes of Health (NIH) has announced a partnership with private entities on a three-faceted scientific initiative to address the opioid crisis.

SAMHSA: Medication treatment for SUD increases significantly

June 12, 2017  |  Julie Miller, Editor in Chief
article
According to SAMHSA’s latest Behavioral Health Barometer, between 2011 and 2015, methadone use increased by 16%, and use of buprenorphine more than doubled.

Total transformation: Phoenix House will dramatically move beyond TC roots

May 23, 2017  |  Gary A. Enos, Editor
article
New Phoenix Life Centers in New York City this summer will signal a major clinical shift for one of the nation's most prominent nonprofit addiction treatment organizations.

Pages

Subscribe to Prescription drug abuse